Inspire Pharmaceuticals, Inc. Eye Drug Fails in Late-Stage Trial; Says Drug Did Not Meet Main Goal

Reuters -- Inspire Pharmaceuticals Inc said a late-stage trial on its experimental eye drug failed to meet the main goal of efficacy, sending its shares down 8 percent in premarket trading.